NCT06596083 The Effects of Ketone Ester Supplementation During a 5 Week Live High, Train Low Altitude Training Camp
| NCT ID | NCT06596083 |
| Status | Recruiting |
| Phase | — |
| Sponsor | KU Leuven |
| Condition | Hypoxia |
| Study Type | INTERVENTIONAL |
| Enrollment | 18 participants |
| Start Date | 2024-09-10 |
| Primary Completion | 2024-10-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 18 participants in total. It began in 2024-09-10 with a primary completion date of 2024-10-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the effects of post-exercise and pre-sleep exogenous ketosis via oral ketone ester supplementation during a 5 week simulated altitude training camp.
Eligibility Criteria
Inclusion Criteria: * Physically fit and regularly involved in physical activity (2-5h per week) * Good health status confirmed by a medical screening * Non-smoking Exclusion Criteria: * Any kind of injury/pathology that is a contra-indication to perform high-intensity exercise * Any kind of injury/pathology that is a contra-indication for exposure to hypoxia * Ongoing pregnancy or breastfeeding * intake of any medication or nutritional supplement that is proven to affect exercise performance during the last month prior to the start of the study * Involvement in elite athletic training at a semi-professional or professional level * Exposure to altitudes higher than 1500 m during the 3 months prior to the start of the study * Blood ferritin levels below 30 ng/mL * Current participation in another research trial * Any other argument to believe that the subject is unlikely to succesfully complete the full study protocol
Contact & Investigator
Chiel Poffé
PRINCIPAL INVESTIGATOR
KU Leuven
Frequently Asked Questions
Who can join the NCT06596083 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Hypoxia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06596083 currently recruiting?
Yes, NCT06596083 is actively recruiting participants. Contact the research team at wout.lauriks@kuleuven.be for enrollment information.
Where is the NCT06596083 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT06596083 clinical trial?
NCT06596083 is sponsored by KU Leuven. The principal investigator is Chiel Poffé at KU Leuven. The trial plans to enroll 18 participants.